 |
|
|
| |
BICTEGRAVIR/FTC/TAF SINGLE-TABLET REGIMEN IN
ADOLESCENTS & CHILDREN: WEEK 48 RESULTS
|
| |
| |
Reported by Jules Levin
CROI 2019 March 4-7 Seattle
WEBCAST: http://www.croiwebcasts.org/console/player/41087?mediaType=slideVideo&
Aditya Gaur1, Mark Cotton2, Carina Rodriguez3, Eric J. McGrath4, Elizabeth Hellstrom5, Afaaf Liberty6, Eva Natukunda7, Pope Kosalaraksa8, Kulkanya Chokephaibulkit9, Heather Maxwell10, Sophia R. Majeed10, Danielle Porter10, Pamela Wong10, Hiba Graham10, Cheryl Pikora10
1St. Jude Children's Research Hospital, Memphis, TN, USA,2Stellenbosch University, Cape Town, South Africa,3University of South Florida, Tampa, FL, USA,4Children's Hospital of Michigan, Detroit, MI, USA,5Be Part Yoluntu Centre, Paarl, South Africa,6Chris Hani Baragwanath Hospital, Johannesburg, South Africa,7Joint Clinical Research Centre, Kampala, Uganda,8Khon Kaen Hospital, Khon Kaen, Thailand,9Mahidol University, Bangkok, Thailand,10Gilead Sciences, Inc, Foster City, CA, USA
|
| |
|
|
|
|
|
